Trials / Completed
CompletedNCT02563132
Carbon Dioxide Insufflation Colonoscopy in IBD Patients
Carbon Dioxide Insufflation Colonoscopy in Inflammatory Bowel Disease Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Vitkovice Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) after the procedure. So far, it has not been studied in inflammatory bowel disease patients. The study was designed to evaluate discomfort after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.
Detailed description
Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) during up to 24 hours after the procedure. So far, it has not been studied in inflammatory bowel disease patients who represent specific patient population indicated for colonoscopy. They are characterized by younger age, structural changes of the colon including intestinal resections and need for repeated and frequently difficult procedures.The study was designed to evaluate discomfort during 24 hours after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Carbon dioxide insufflation | Carbon dioxide insufflation during diagnostic colonoscopy |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-09-29
- Last updated
- 2016-06-01
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02563132. Inclusion in this directory is not an endorsement.